Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7339 p264-265
5 March 2005

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

News feature

Revised Duthie report emphasises the role of the multidisciplinary team

A revision of the Duthie report, led by the Hospital Pharmacists Group and published this week by the Royal Pharmaceutical Society, emphasises the role of the multidisciplinary team in safe and secure handling of medicines. Gareth Jones, editor of Hospital Pharmacist, reports


Duthie reportNumerous changes in the legislation and environment of medicines supply and use have occurred in the past 17 years. There are now many more prescribers, new ways of managing medicines (such as self-administration by patients in hospitals), an increased emphasis on clinical governance and a growing awareness of medication errors. These factors make the publication this week by the Royal Pharmaceutical Society of “The safe and secure handling of medicines: a team approach” particularly timely. It is a revision of the Department of Health’s 1988 “Guidelines for the safe and secure handling of medicines” (the Duthie report) and is written to provide practical advice to all health professionals involved in handling medicines. The revised report includes advice for primary care practitioners — a recognition that patients are on a single care pathway.

The report sets out the principles of achieving safe and secure management of medicines and outlines the medicines trail. The medicines trail covers all the processes involved in the handling of a medicinal product from the initiation of treatment through to administration and disposal of waste material. Specific advice is then provided in areas of drug use (eg, wards, operating departments, intensive therapy units, NHS ambulances, etc). More general topics such as training and personnel, and return of medicines for destruction are also covered. A full list of the topics covered is provided in the Panel below and examples of the guidance are given in the Panel on p265. The intention is that health care professionals will read the introductory chapters and then the areas of guidance relevant to their practice — indeed a reader who read the document from cover to cover might find it somewhat repetitive.

Areas of medicines use covered in the new report

· Clinical trials
· Community health services
· Community psychiatric services
· Controlled Drugs
· Coronary care units
· Drug addiction treatment units
· Emergency departments
· Intensive therapy units
· Midwives
· Minor injuries units
· NHS ambulances
· Operating departments
· Outpatient departments
· Self-administration of medicines
· Transplant units
· Walk-in centres
· Wards

Examples of guidance provided in the report

Wards “All wards should have standard operating procedures covering each of the activities concerned with medicines use to ensure the safety and security of medicines stored and used in them. Appropriate pharmaceutical advice must be sought in the development of systems for the safe and secure handling of medicines.”

Clinical trials “The patient information sheet (part of the informed consent package) should be available when medicines are given as part of a clinical trial.”

Walk-in centres and minor injury units “Each walk-in centre/minor injuries unit site should have a system of standard operating procedures covering each of the activities concerned with medicines use to ensure the safety and security of medicines stored and used in it.”

Training and personnel “All staff involved in the handling of medicines should be appropriately trained with regard to safety and security of medicines and with regard to safeguarding themselves and those under their supervision from any risks posed by products (eg, cytotoxic or radioactive medicines).”

Return of medicines for destruction “Medicines brought [into hospital] by the patient remain the property of the patient and may only be sent to the pharmacy for destruction with the prior agreement of the patient or his/her agent. Details of patients’ own medicines sent to the pharmacy for destruction should be recorded.”

Community health services “Each clinic site should have a system of standard operating procedures covering each of the activities concerned with medicines use to ensure the safety and security of medicines stored and used in it. Appropriate pharmaceutical advice must be taken in the development of systems for the safe and secure handling of medicines.”

Fills in the gaps

According to Roger Tredree, chief pharmacist at St George’s Hospital, London, and an editor of the report, it fills in the gaps between legislation and NHS guidance, and is an authoritative document that can be used on a day-to-day basis to support professional practice and underpin medicines risk management.

Gillian Arr-Jones, senior professional adviser pharmacist at the Healthcare Commission and an editor of the report, comments that “Standards for better health”, the new NHS performance framework which comes into force next month, has a core safety standard for handling medicines safely and securely. The revision of the Duthie report gives guidance on setting up and achieving safe systems. “This is complementary guidance,” she says, adding that the report provides “a reminder that you need standard operating procedures in settings throughout the organisation wherever medicines are being handled”. The report provides advice on the safe, secure and legal handling of medicines by health care professionals; clinical decisions such as choice, dose and frequency are not considered.

New legislation and guidance have been incorporated into the report, along with additional chapters for areas of medicine use which have developed since the last report, ie, walk-in centres and self-administration of medicines in hospital. The text has also been updated to include new nomenclature. Another change welcomed by Ms Arr-Jones is the fact the report now covers the use of medicines, whatever setting that might be. “It is applicable to the private sector, too,” she says. “In recent years, more NHS patients have been going through the private sector so it is welcome that there is a level playing field.”

Ms Arr-Jones also supports the philosophy of the team approach to medicines management involving other members of the multidisciplinary team. She comments: “There is a recognition that there is benefit to pharmaceutical advice wherever medicines are used, even if there is not a pharmacist available employed on the site.”

An important addition to the report for hospital pharmacists is the introduction of advice on the use of patients’ own medicines and self-administration from bedside lockers. Richard Needle, chief pharmacist for Essex Rivers Healthcare NHS Trust and another editor of the report, says: “A high proportion of acute hospitals have moved away from the drug trolley with the nurse handing the drugs out to the patient to a system where patients are empowered to look after their own medicines whenever possible.” He adds: “Having medicines located all over the ward creates a significant security risk.”

Among the recommendations in the report are that the patient’s agreement to self-administer should be recorded and that organisations should have a policy on self-administration. Dr Needle believes that anyone with responsibility for medicines on wards should consult this report.

Primary care trusts have responsibility for the safe handling of medicines for their provider services in a range of settings from community hospitals to community clinics. According to Theresa Rutter, specialist in community health services at London, Eastern and South East Specialist Pharmacy Services, this report will be an invaluable reference and support for primary care trusts in ensuring good practice and also when gathering evidence to meet the new health care standards. “It will be the core reference document for all aspects of safe and secure handling of medicines,” she says. “The update of Duthie has been eagerly anticipated. It is not only an essential resource for pharmacists, but is also useful for all the other health professionals to whom we provide advice.”

Although the report is not directed specifically at community pharmacists, Dr Needle suggests that all those involved in medicines supply may find much of use in it. “It does not specifically address areas like care homes, but there are parallels to be drawn about safe and secure handling of medicines in those environments, by looking at what goes on in a hospital,” he says. “Community pharmacists could easily produce a checklist of the issues they should be looking at by extrapolating from the report, particularly the early chapters that set the principles (eg, the medicines trail) which are sufficiently general.”

Broken down into sections

How to obtain a copy of the revised report

A copy of “The safe and secure handling of medicines: a team approach” can be obtained from the practice guidance section of the Royal Pharmaceutical Society’s website.

A hard copy can be purchased from the Society. The price is £20 for members of the Society and £30 for non-members (including postage and packing). Cheques should be made payable to “Royal Pharmaceutical Society” and sent to Lorraine Fearon, Royal Pharmaceutical Society, 1 Lambeth High Street, London SE1 7JN. Payment can also be made by Mastercard, Visa or Switch. Further information is available from Lorraine Fearon (tel 020 7572 2409; e-mail lorraine.fearon@rpsgb.org).

Doctors, dentists, nurses and other health care professionals who are involved with medicines should all consult the report, according to Professor Tredree. The report is broken down into sections so, for example, midwives can focus on a section specific to them, rather than having to review the entire 111 pages.

Barbara Stuttle, chairwoman of the Association for Nurse Prescribers, was involved in the consultation process. She believes that all nurses involved with medicines, whether prescribing, using patient group directions or administering, should read the report. She comments: “It is a timely document with the implications of Shipman. This will help us review our policies and procedures to ensure that it safe to prescribe, supply or administer medicines. This report is unique because it is about a team approach, ie, a joint responsibility rather than just one profession — that is valuable and important. This report will be much appreciated.”

The Hospital Pharmacists Group selected the members of the review group in 1997 after the Society was encouraged to update the Duthie report by the Department of Health. The revised document was then passed to the Department of Health for comments and feedback was sought from other relevant groups. Endorsements have also been secured from the chief pharmaceutical advisers for England and Wales and the chief pharmaceutical officers for Scotland and Northern Ireland.

This report has taken almost eight years to produce. According to Professor Tredree, this is because so much has been going on in the health service that before it has been possible to publish, further amendments have been required.

Dr Needle further explains that the review process initially produced a risk management overview which the Royal Pharmaceutical Society’s Hospital Pharmacists Group committee believed did not meet the requirements of the health professionals that would be using it. This was then revised to reintroduce the more practical advice that was so valuable in the original Duthie report. He adds that there was also a lengthy consultation period and a decision to ensure the support of the devolved administrations, which has now been achieved.

The changes expected in Controlled Drug legislation as a result of the Shipman inquiry means that a revision of appendix 1 in the report, which covers this topic, may be required soon. An e-mail box — duthie@ rpsgb.org — has been set up to receive comments on the report and suggestions for potential revisions. Any comments sent in will be dealt with by a panel of experts who have been involved in producing the revised document. Dr Needle hopes that the report will be updated in a couple of years. One significant gap for hospital practice he identified is the lack of advice on medical gases and he hopes that this may be addressed in a future revision.

Chronology of reports on the safe and secure handling of medicines

· Aitken report — 1958
· Annis Gillie report — 1970
· Roxburgh report — 1972
· Duthie report — 1988
· “The safe and secure handling of medicines: a team approach” — 2005

“The safe and secure handling of medicines: a team approach”, is the fifth report on this topic since the subject was first reviewed in 1958 (see Panel). The work over the past eight years has produced a document which should be useful and indeed vital for all health professionals who are involved in the handling of medicines. As Ms Arr-Jones says, people have been waiting for the revision of the Duthie report because there is no other single source of information on handling medicines for hospital and managed settings. It is to be hoped that, as intended, all members of the multidisciplinary team that are involved in medicines make use of the advice provided.

Back to Top


©The Pharmaceutical Journal